dactinomycin and 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin

dactinomycin has been researched along with 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, FM; Mullins, TD; Newman, RA; Rose, KM; Wassermann, K1
Acton, EM; Andersson, BS; Bakic, M; Mullins, TD; Newman, RA; Silberman, LE; Wassermann, K; Zwelling, LA1

Other Studies

2 other study(ies) available for dactinomycin and 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin

ArticleYear
Selective inhibition of human ribosomal gene transcription by the morpholinyl anthracyclines cyanomorpholinyl- and morpholinyldoxorubicin.
    Cancer research, 1988, Jul-15, Volume: 48, Issue:14

    Topics: Dactinomycin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Microscopy, Electron; Ribosomes; RNA Polymerase I; Transcription, Genetic

1988
Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Cancer research, 1986, Volume: 46, Issue:8

    Topics: Antibiotics, Antineoplastic; Cell Nucleolus; Cell Survival; Cells, Cultured; Dactinomycin; DNA, Neoplasm; Doxorubicin; Humans; Leukemia; RNA, Neoplasm; Structure-Activity Relationship

1986